| Boosting half-life and effector functions of therapeutic antibodies by Fc-engineering: An interaction-function review MHG Fonseca, GP Furtado, MRL Bezerra, LQ Pontes, CFC Fernandes International journal of biological macromolecules 119, 306-311, 2018 | 28 | 2018 |
| Epigenetic reprogramming in cancer: From diagnosis to treatment PMS Costa, SLA Sales, DP Pinheiro, LQ Pontes, SSA Maranhão, ... Frontiers in cell and developmental biology 11, 1116805, 2023 | 15 | 2023 |
| Progress on phage display technology: tailoring antibodies for cancer immunotherapy RKA França, IC Studart, MRL Bezerra, LQ Pontes, AMA Barbosa, ... Viruses 15 (9), 1903, 2023 | 6 | 2023 |
| Ethnopharmacological and Genetic Study on the Treatment of Mental Disorders: a Systematic Review CKT Lima, LQ Pontes, LG Pinho, MRL Bezerra, W da Silva Barroso, ... International Archives of Medicine 8, 2015 | 2 | 2015 |
| Ultrastructural aspects of cranial and peripheric nerves of cronically diabetic and malnourished rats: a short biochemical panorama A de Oliveira Saraiva, LQ Pontes, LG Pinho, MRL Bezerra, HA Braga, ... International Archives of Medicine 8, 2015 | 1 | 2015 |
| Physical Activity at Different Life Stages and Its Consequence on the Initial Immunization and Inflammatory Response Against COVID-19 PAQ Rossi, R Gomes, TC do Nascimento Salazar, EML Barros, ... Journal of Physical Activity and Health 1 (aop), 1-9, 2024 | | 2024 |
| Reconversion of rituximab’s scFv into FvFc: a suitable format to understand CDR mutations of monoclonal antibodies MR Bezerra, PEG Saraiva Filho, LQ Pontes, DP Pinheiro, RPS Araújo, ... Instituto de Tecnologia em Imunobiológicos, 2024 | | 2024 |
| Proposição de fragmentos de anticorpo de domínio variável (scFv) anti-CD20 para o desenvolvimento de bispecíficos t-cell engager (BiTE) LQ Pontes | | 2023 |
| CAR-T Cells and Other Related Technologies MRL Bezerra, LQ Pontes, IC Studart, B de Sousa Lima, GP Furtado The Golden Guide to Oncologic Pharmacy, 281-314, 2022 | | 2022 |
| Selection of human antibody fragments by phage display: development of new anti-CD19 molecules for CAR-T cell therapies MRL Bezerra, LQ Pontes, AQ Maranhão, GP Furtado Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2021 | | 2021 |
| Construção, por desenho racional, e caracterização de variantes de afinidade da região variável do anticorpo monoclonal Rituximabe LQ Pontes | | 2019 |
| Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody LQ Pontes, MRL Bezerra, MHG Fonseca, MR Lourenzoni, GP Furtado | | 2019 |
| Construction of a scFv library using directed evolution for rituximab-based therapies: using phage display towards antibody affinity maturation MRL Bezerra, AQ Maranhao, IC Studart, LQ Pontes, MHG Fonseca, ... | | 2019 |
Gilvan Pessoa FurtadoPesquisador da Fiocruz - CearáVerified email at fiocruz.br
Gilvan Pessoa FurtadoPesquisador da Fiocruz - CearáVerified email at fiocruz.br